SE530442C2 - Diagnos av karies - Google Patents
Diagnos av kariesInfo
- Publication number
- SE530442C2 SE530442C2 SE0602214A SE0602214A SE530442C2 SE 530442 C2 SE530442 C2 SE 530442C2 SE 0602214 A SE0602214 A SE 0602214A SE 0602214 A SE0602214 A SE 0602214A SE 530442 C2 SE530442 C2 SE 530442C2
- Authority
- SE
- Sweden
- Prior art keywords
- dentin
- caries
- carious
- tooth
- dental
- Prior art date
Links
- 208000002925 dental caries Diseases 0.000 title description 43
- 238000003745 diagnosis Methods 0.000 title 1
- 210000004268 dentin Anatomy 0.000 claims description 48
- 238000000034 method Methods 0.000 claims description 11
- -1 hexose ester Chemical class 0.000 claims description 5
- 238000010521 absorption reaction Methods 0.000 claims description 4
- 238000004566 IR spectroscopy Methods 0.000 claims description 2
- 229930182478 glucoside Natural products 0.000 claims 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 20
- 238000001228 spectrum Methods 0.000 description 19
- 150000002148 esters Chemical class 0.000 description 14
- 241000894006 Bacteria Species 0.000 description 12
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 10
- 239000004310 lactic acid Substances 0.000 description 10
- 235000014655 lactic acid Nutrition 0.000 description 10
- 210000003127 knee Anatomy 0.000 description 7
- 108010005094 Advanced Glycation End Products Proteins 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 102000008186 Collagen Human genes 0.000 description 5
- 108010035532 Collagen Proteins 0.000 description 5
- 229920001436 collagen Polymers 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000003902 lesion Effects 0.000 description 5
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 4
- 230000002378 acidificating effect Effects 0.000 description 4
- 238000002845 discoloration Methods 0.000 description 4
- 125000004185 ester group Chemical group 0.000 description 4
- 239000008188 pellet Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 102000029816 Collagenase Human genes 0.000 description 2
- 108060005980 Collagenase Proteins 0.000 description 2
- 238000001157 Fourier transform infrared spectrum Methods 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 238000009412 basement excavation Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 229960002424 collagenase Drugs 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000032050 esterification Effects 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- MNQZXJOMYWMBOU-VKHMYHEASA-N D-glyceraldehyde Chemical compound OC[C@@H](O)C=O MNQZXJOMYWMBOU-VKHMYHEASA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000004763 bicuspid Anatomy 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 150000001840 cholesterol esters Chemical class 0.000 description 1
- 230000011382 collagen catabolic process Effects 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 239000005548 dental material Substances 0.000 description 1
- 201000009241 dentin caries Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-L glutamate group Chemical group N[C@@H](CCC(=O)[O-])C(=O)[O-] WHUUTDBJXJRKMK-VKHMYHEASA-L 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- AYEKKSTZQYEZPU-RYUDHWBXSA-N pentosidine Chemical compound OC(=O)[C@@H](N)CCCCN1C=CC=C2N=C(NCCC[C@H](N)C(O)=O)N=C12 AYEKKSTZQYEZPU-RYUDHWBXSA-N 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/50—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
- A61B6/51—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications for dentistry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0082—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
- A61B5/0088—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for oral or dental tissue
-
- A61B6/14—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C3/00—Dental tools or instruments
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dentistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medical Informatics (AREA)
- Engineering & Computer Science (AREA)
- Pathology (AREA)
- Surgery (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- High Energy & Nuclear Physics (AREA)
- Audiology, Speech & Language Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Optics & Photonics (AREA)
- Radiology & Medical Imaging (AREA)
- Cosmetics (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0602214A SE530442C2 (sv) | 2006-10-18 | 2006-10-18 | Diagnos av karies |
| PCT/SE2007/000923 WO2008048170A1 (en) | 2006-10-18 | 2007-10-18 | Diagnosis of caries |
| EP07835124A EP2079357A4 (de) | 2006-10-18 | 2007-10-18 | Diagnose von karies |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0602214A SE530442C2 (sv) | 2006-10-18 | 2006-10-18 | Diagnos av karies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE0602214L SE0602214L (sv) | 2008-04-19 |
| SE530442C2 true SE530442C2 (sv) | 2008-06-10 |
Family
ID=39314284
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE0602214A SE530442C2 (sv) | 2006-10-18 | 2006-10-18 | Diagnos av karies |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP2079357A4 (de) |
| SE (1) | SE530442C2 (de) |
| WO (1) | WO2008048170A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012172071A2 (en) | 2011-06-15 | 2012-12-20 | Orasolv Ab | Detection and removal of carious dentin tissue. |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050238058A1 (en) * | 2004-04-26 | 2005-10-27 | Peirce Kenneth L Jr | Synchronization of upstream and downstream data transfer in wireless mesh topologies |
-
2006
- 2006-10-18 SE SE0602214A patent/SE530442C2/sv unknown
-
2007
- 2007-10-18 WO PCT/SE2007/000923 patent/WO2008048170A1/en active Application Filing
- 2007-10-18 EP EP07835124A patent/EP2079357A4/de not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP2079357A4 (de) | 2010-02-17 |
| WO2008048170A1 (en) | 2008-04-24 |
| SE0602214L (sv) | 2008-04-19 |
| EP2079357A1 (de) | 2009-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Spencer et al. | Molecular structure of acid-etched dentin smear layers-in situ study | |
| Yoneda et al. | Relationship between the β-galactosidase activity in saliva and parameters associated with oral malodor | |
| Folwaczny et al. | Subgingival calculus detection with fluorescence induced by 655 nm InGaAsP diode laser radiation | |
| Leonhardt et al. | Microbiologic diagnostics at titanium implants | |
| Shin et al. | Effects of a composition containing lactoferrin and lactoperoxidase on oral malodor and salivary bacteria: a randomized, double-blind, crossover, placebo-controlled clinical trial | |
| Junior et al. | In vitro action of various carbamide peroxide gel bleaching agents on the microhardness of human enamel | |
| RYKKE et al. | Interindividual and longitudinal studies of amino acid composition of pellicle collected in vivo | |
| Almhöjd et al. | Analysis of carious dentine using FTIR and ToF-SIMS | |
| de Faveri et al. | The effect of Brazilian propolis type-3 against oral microbiota and volatile sulfur compounds in subjects with morning breath malodor | |
| CN111356409A (zh) | 用于侦测口内疾病及确定个人化的治疗方案的系统及方法 | |
| Sahin et al. | Antibacterial efficacy and remineralization capacity of glycyrrhizic acid added casein phosphopeptide‐amorphous calcium phosphate | |
| Hara et al. | Carbohydrate components of the gingival exudate | |
| SE530442C2 (sv) | Diagnos av karies | |
| Seredin et al. | Comparative analysis of dentine and gingival fluid molecular composition and protein conformations during development of dentine caries: A pilot study | |
| Nichols et al. | Prostaglandin E2 secretion from gingival fibroblasts treated with interleukin‐1β: effects of lipid extracts from Porphyromonas gingivalis or calculus | |
| Wang et al. | Collagen stabilization by natural cross-linkers: A qualitative and quantitative FTIR study on ultra-thin dentin collagen model | |
| TWI467176B (zh) | 用於口腔健康之代謝物及其用途 | |
| JP3611638B2 (ja) | ヒトコラゲナーゼ活性阻害剤 | |
| Ulpiyah et al. | Inhibition of namnam (Cynometra cauliflora L.) leaves extract on the growth of Porphyromonas gingivalis | |
| Majiene et al. | Antifungal and antibacterial activity of propolis | |
| Hill et al. | Detection of caries and composite resin restorations by near-infrared Raman spectroscopy | |
| Inasu et al. | Evaluation of serum and salivary sialic acid and nitric oxide levels in chronic periodontitis patients | |
| Soekanto et al. | The effect of casein phosphopeptide-amorphous calcium phosphate-propolis chewing gum on calcium and phosphate ion levels in caries-free subject's saliva and streptococcus mutans biofilm formation | |
| Rodrigues et al. | In vitro evaluation of the influence of air abrasion on detection of occlusal caries lesions in primary teeth | |
| Marsillac et al. | Effect of time in hardness test on artificially demineralized human dental enamel |